期刊文献+

不同质子泵抑制剂治疗消化性溃疡出血的疗效比较分析 被引量:9

Comparative Analysis of the Efficacy of Different Proton Pump Inhibitors in the Treatment of Peptic Ulcer Bleeding
下载PDF
导出
摘要 目的:比较不同质子泵抑制剂治疗消化性溃疡出血的疗效,以供临床工作参考。方法:选择2009年10月-2012年9月笔者所在医院收治的105例消化性溃疡出血患者作为研究对象,根据随机法分为A组和B组,均接受包括抗感染、止血、胃黏膜保护、抑酸等对症治疗。A组应用注射用奥美拉唑钠,B组应用注射用泮托拉唑钠。治疗7d后,对比两组患者的有效性和安全性。结果:B组总有效率明显高于A组,差异有统计学意义(P<0.05)。治疗期间,两组不良反应发生率比较差异无统计学意义(P>0.05)。结论:质子泵抑制剂在消化性溃疡出血的治疗中具有重要的价值,其中泮托拉唑疗效具有一定的优越性,临床应用前景较好。 Objective: To compare the different proton pump inhibitors in the treatment of peptic ulcer bleeding, clinical work for reference.Methods: From October 2009 to September 2012, 105 cases as research subjects, grouped according to the random method was accepted, including anti-infection, bleeding, symptomatic treatment of gastric mucosal protective, acid-suppressing patients with peptic ulcer bleeding. Group A was given omeprazole, group B was given pantoprazole.Contrasted the difference of efficacy and safety.Results: The effectiveness of group B was significantly higher than group A, the difference was statistically signifieant(P〈0.05).The incidence of adverse reactions was not statistically significant between two groups(P〉O.O5).Conclusion: Proton pump inhibitors in the treatment of peptic ulcer bleeding has an important value, the efficacy of pantoprozole has certain advantages, better prospects for clinical application.
作者 谢银兰
出处 《中外医学研究》 2013年第22期9-10,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 质子泵抑制剂 消化性溃疡出血 奥美拉唑 泮托拉唑 Proton pump inhibitors Peptic ulcer bleeding Omeprazole Pantoprazole
  • 相关文献

参考文献10

二级参考文献33

  • 1陈百芳.洛赛克治疗难愈性溃疡38例疗效观察[J].内镜,1995,12(4):241-242. 被引量:9
  • 2陈福生,卢杰夫,王笑茹.阶梯性疗法对预防消化性溃疡复发的疗效观察[J].河北医学,2006,12(2):99-100. 被引量:30
  • 3成虹,胡伏莲,李江.幽门螺杆菌耐药性对其根除治疗影响的研究[J].中华医学杂志,2006,86(38):2679-2682. 被引量:97
  • 4国家药典委员会编临床用药须知[M].2005年版.北京:人民卫生出版社,2005,283.
  • 5Eriksson S,Langstrom G,Rikner L,et al.Omeprazole and H2-receptor antagonists in the accnte treatment of duodenal ulcer,gastric ulcer and reflux oesopHagitis:a metaanalysis[J].Eur J Gastroenterol Hepatol,1995,7(5):467.
  • 6Scott IJ,Dunn GL,MallarkeyG.,et al.Esomeprazole-areview of its'use in the management of acidrelated disorders[J].Drags.2002,62(10):1503-1538.
  • 7中华医学会消化病学分会.幽门螺杆菌若干临床方面的共识意见.中华内科杂志,:316-316.
  • 8Malferthener P, Megeraud F, O' morain C, et al. Curent concepts in management of Helicobacter pylori infection-The Maastricht Ⅱ-2000 consensus report [J]. Aliment Pharmacol Ther,2002,16: 167.
  • 9Malfertheiner P, Megraud F, O' Morain C, et al Current concepts in the management of Helicobacter pylori infection: the MaastrichtⅢ Consensus Report [J]. Gut,2007,56:772-781.
  • 10中华医学会消化病学分会幽门螺杆菌学组/全国幽门螺杆菌科研协作组.中国幽门螺杆菌耐药状况以及耐药对治疗的影响-全国多中心临床研究.胃肠病,:525-530.

共引文献125

同被引文献61

  • 1邹多武,许国铭,李兆申,尹宁.静脉滴注潘妥拉唑对健康人胃内24小时pH影响[J].中华消化杂志,2005,25(4):236-236. 被引量:79
  • 2潘国宗.现代胃肠病学[M].北京:科学出版社,1994.1246.
  • 3Leonard J, Marshall J K, Moayuedi P.Systemetic review of the risk of enteric infection in patients taking acid supprerssion[J].Am J Gastroenterolm, 2007, 102(9): 2047-2056.
  • 4Howell M D, Novack V, Grgurich P, et al.Iatrogenic gastric acid suppression and the risk of nosocomial clostridinm difficile infection [J]. Arch Intern Med, 2010, 170(9): 784-790.
  • 5Targownik L E, Lix L M, Metge C J, et al.Use of proton pump inhibitors and risk of osteporosis -related fractures[J].CMAJ, 2008, 179(4): 319-326.
  • 6He P M, Maddox T M, Wang L, et al.Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[J].JAMA, 2009, 301(9): 937-944.
  • 7李云兰.奥美拉唑联合阿莫西林治疗消化性溃疡50例观察[J].中国医院药学杂志,2000,20(10):618-619.
  • 8孙海丰.消化性溃疡治疗进展分析[J].健康大视野,2013,21(3):558-559.
  • 9王智康,袁寿忠,董政,刘樾,潘维诚.潘托拉唑预防重度烧伤应激性溃疡出血临床观察[J].实用临床医药杂志,2007,11(6):73-73. 被引量:5
  • 10Laine L,Jensen DM. Managerment of patients with ulcer bleeding[J]. Am J Gastroenterol, 2012,107(3) : 345-360.

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部